Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34](S0959804919304095)(10.1016/j.ejca.2019.07.009)

Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, French LE, Berking C, Schilling B, Haferkamp S, Fröhling S, von Kalle C, Brinker TJ (2019)


Publication Type: Journal article, Erratum

Publication year: 2019

Journal

DOI: 10.1016/j.ejca.2019.10.003

Abstract

Dr. Titus J. Brinker regrets that he originally forgot to disclose the following potential conflict of interest: Dr. Brinker owns a company that develops mobile apps (Smart Health Heidelberg GmbH, Handschuhsheimer Landstr. 9/1, 69120 Heidelberg). Dr. Brinker asked for this corrigendum himself for the reason that a paragraph of this perspective article discusses mole monitoring apps. No third party was involved in instructing this corrigendum. Dr. Brinker would like to apologise for any inconvenience caused.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Sondermann, W., Utikal, J.S., Enk, A.H., Schadendorf, D., Klode, J., Hauschild, A.,... Brinker, T.J. (2019). Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34](S0959804919304095)(10.1016/j.ejca.2019.07.009). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2019.10.003

MLA:

Sondermann, Wiebke, et al. "Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34](S0959804919304095)(10.1016/j.ejca.2019.07.009)." European Journal of Cancer (2019).

BibTeX: Download